Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 2433405)

1.

Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.

Skjeldal OH, Stokke O, Refsum S, Norseth J, Petit H.

J Neurol Sci. 1987 Jan;77(1):87-96.

PMID:
2433405
2.

Disorders related to the metabolism of phytanic acid.

Stokke O, Skjeldal OH, Høie K.

Scand J Clin Lab Invest Suppl. 1986;184:3-10. Review.

PMID:
2438746
3.

[Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].

Molzer B, Stöckler S, Bernheimer H.

Wien Klin Wochenschr. 1992;104(21):665-70. Review. German.

PMID:
1282286
4.

Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.

Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD, Gibberd FB.

J Neurochem. 2002 Mar;80(5):727-35. Review.

PMID:
11948235
5.

Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.

Wierzbicki AS.

Biochem Soc Trans. 2007 Nov;35(Pt 5):881-6. Review.

PMID:
17956237
6.

Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.

Wanders RJ, Komen JC.

Biochem Soc Trans. 2007 Nov;35(Pt 5):865-9. Review.

PMID:
17956234
7.

Clinical biochemistry of peroxisomal disorders.

Kaiser E, Kramar R.

Clin Chim Acta. 1988 Mar 31;173(1):57-80. Review.

PMID:
3289796
9.

[Peroxisomal hereditary diseases].

Chandoga J, Tomková M, Hlavatá A.

Bratisl Lek Listy. 1997 Jan;98(1):32-42. Review. Slovak.

PMID:
9264803
10.

Phytanic acid: production from phytol, its breakdown and role in human disease.

van den Brink DM, Wanders RJ.

Cell Mol Life Sci. 2006 Aug;63(15):1752-65. Review.

PMID:
16799769
11.

History of the cerebrohepatorenal syndrome of Zellweger and other peroxisomal disorders.

Zellweger H, Maertens P, Superneau D, Wertelecki W.

South Med J. 1988 Mar;81(3):357-64. Review.

PMID:
2450404
12.

[Refsum's disease. Apropos of 2 cases disclosed by myocardiopathy].

Millaire A, Warembourg A, Leys D, Tison E, Tondeux S, De Groote P, Ketelers JY, Fourrier F, Petit H, Ducloux G.

Ann Cardiol Angeiol (Paris). 1990 Mar;39(3):173-8. Review. French.

PMID:
1693053
13.

New approaches in peroxisomal disorders.

Moser HW.

Dev Neurosci. 1987;9(1):1-18. Review.

PMID:
3297624
14.

The peroxisome and the eye.

Folz SJ, Trobe JD.

Surv Ophthalmol. 1991 Mar-Apr;35(5):353-68. Review.

PMID:
1710072
15.

Diagnosis of peroxisomal disorders with neurological involvement.

Molzer B.

Padiatr Padol. 1993;28(1):43-8. Review.

PMID:
8446428
16.

Elucidation of the metabolic error in Refsum's disease: strategy and tactics.

Steinberg D.

Adv Neurol. 1978;21:113-24. Review. No abstract available.

PMID:
83783
17.

Organelle pathology in metabolic neuromuscular disease: an overview.

Becker LE.

Can J Vet Res. 1990 Jan;54(1):1-14. Review.

18.

[Refsum disease].

Morooka K.

Nihon Rinsho. 2002 Sep;60 Suppl 9:842-5. Review. Japanese. No abstract available.

PMID:
12387094
19.

[Refsum disease].

Suzuki Y.

Nihon Rinsho. 2001 Mar;59 Suppl 3:326-8. Review. Japanese. No abstract available.

PMID:
11347087
20.

Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy.

Rüether K, Baldwin E, Casteels M, Feher MD, Horn M, Kuranoff S, Leroy BP, Wanders RJ, Wierzbicki AS.

Surv Ophthalmol. 2010 Nov-Dec;55(6):531-8. doi: 10.1016/j.survophthal.2010.03.007. Epub 2010 Sep 20. Review.

PMID:
20850855
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk